LeMaitre VascularLMAT
Market Cap: $2B
About: LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
Employees: 630
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
300% more call options, than puts
Call options by funds: $296K | Put options by funds: $74K
150% more funds holding in top 10
Funds holding in top 10: 2 [Q1] → 5 (+3) [Q2]
73% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 26
24% more capital invested
Capital invested by funds: $1.36B [Q1] → $1.69B (+$327M) [Q2]
8% more funds holding
Funds holding: 242 [Q1] → 261 (+19) [Q2]
0.55% less ownership
Funds ownership: 92.05% [Q1] → 91.5% (-0.55%) [Q2]
7% less repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 98
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
JMP Securities Daniel Stauder 60% 1-year accuracy 3 / 5 met price target | 12%upside $100 | Market Outperform Maintained | 20 Aug 2024 |
Barrington Research Michael Petusky 52% 1-year accuracy 26 / 50 met price target | 8%downside $82 | Outperform Maintained | 2 Aug 2024 |